back to cluster viewer

cluster path 1110100001110110

48 words, 15,163 tokens freq alpha suffix

Words in frequency order
1 recommended 14,822
2 mistaken 102
3 envisaged 97
4 stipulated 54
5 prized 14
6 abiding 7
7 cost-prohibitive 6
8 reinterpreted 6
9 condoned 5
10 cost-competitive 4
11 prescribable 4
12 16,611 2
13 aqp-positive 2
14 k.e 2
15 participant-dependent 2
16 renormalized 2
17 0.003f/ml 1
18 13,843 1
19 14,688 1
20 149,539 1
21 15,032 1
22 15,063 1
23 15,115 1
24 15,431 1
25 15,793 1
26 151,076 1
27 158,640 1
28 16,583 1
29 16,789 1
30 16,823 1
31 16144 1
32 17,018 1
33 180,800 1
34 19,170 1
35 3,182 1
36 300,000/mm3 1
37 32,965 1
38 52,491 1
39 5953 1
40 aqp5-positive 1
41 half-sites 1
42 inadvised 1
43 prevention/regression 1
44 proton-beam 1
45 re-flagged 1
46 thematized 1
47 £43,000 1
48 €10,000 1

Words in alphabetical order
1 0.003f/ml 1
2 13,843 1
3 14,688 1
4 149,539 1
5 15,032 1
6 15,063 1
7 15,115 1
8 15,431 1
9 15,793 1
10 151,076 1
11 158,640 1
12 16,583 1
13 16,611 2
14 16,789 1
15 16,823 1
16 16144 1
17 17,018 1
18 180,800 1
19 19,170 1
20 3,182 1
21 300,000/mm3 1
22 32,965 1
23 52,491 1
24 5953 1
25 abiding 7
26 aqp-positive 2
27 aqp5-positive 1
28 condoned 5
29 cost-competitive 4
30 cost-prohibitive 6
31 envisaged 97
32 half-sites 1
33 inadvised 1
34 k.e 2
35 mistaken 102
36 participant-dependent 2
37 prescribable 4
38 prevention/regression 1
39 prized 14
40 proton-beam 1
41 re-flagged 1
42 recommended 14,822
43 reinterpreted 6
44 renormalized 2
45 stipulated 54
46 thematized 1
47 £43,000 1
48 €10,000 1

Words in suffix order
1 €10,000 1
2 £43,000 1
3 180,800 1
4 158,640 1
5 19,170 1
6 16,611 2
7 15,431 1
8 52,491 1
9 15,032 1
10 3,182 1
11 16,823 1
12 13,843 1
13 5953 1
14 15,063 1
15 16,583 1
16 15,793 1
17 300,000/mm3 1
18 16144 1
19 15,115 1
20 32,965 1
21 151,076 1
22 17,018 1
23 14,688 1
24 149,539 1
25 16,789 1
26 recommended 14,822
27 envisaged 97
28 re-flagged 1
29 condoned 5
30 inadvised 1
31 stipulated 54
32 reinterpreted 6
33 renormalized 2
34 prized 14
35 thematized 1
36 k.e 2
37 prescribable 4
38 cost-prohibitive 6
39 aqp5-positive 1
40 aqp-positive 2
41 cost-competitive 4
42 abiding 7
43 0.003f/ml 1
44 proton-beam 1
45 mistaken 102
46 prevention/regression 1
47 half-sites 1
48 participant-dependent 2